BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20800103)

  • 1. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.
    Barker JN; Byam CE; Kernan NA; Lee SS; Hawke RM; Doshi KA; Wells DS; Heller G; Papadopoulos EB; Scaradavou A; Young JW; van den Brink MR
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1541-8. PubMed ID: 20800103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.
    Barker JN; Boughan K; Dahi PB; Devlin SM; Maloy MA; Naputo K; Mazis CM; Davis E; Nhaissi M; Wells D; Cooper C; Ponce DM; Kernan N; Scaradavou A; Giralt SA; Papadopoulos EB; Politikos I
    Blood Adv; 2019 Apr; 3(7):939-944. PubMed ID: 30917950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic transplant potential of unrelated cord blood: critical issues.
    Kögler G; Callejas J; Hakenberg P; Enczmann J; Adams O; Däubener W; Krempe C; Göbel U; Somville T; Wernet P
    J Hematother; 1996 Apr; 5(2):105-16. PubMed ID: 8723785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Ethnicity on Donor Search Results for Children Requiring Stem Cell Transplantation.
    DiLabio J; Doyle J; Alexander S; Gupta S; Punnett A
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e154-7. PubMed ID: 25333838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.
    Kosuri S; Wolff T; Devlin SM; Byam C; Mazis CM; Naputo K; Davis E; Paulson J; Nhaissi M; Wells DS; Dahi P; Giralt SA; Jakubowski A; Perales MA; Shaffer BC; Scaradavou A; Ponce DM; Barker JN
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):965-970. PubMed ID: 28263918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
    Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.
    Ponce DM; Zheng J; Gonzales AM; Lubin M; Heller G; Castro-Malaspina H; Giralt S; Hsu K; Jakubowski AA; Jenq RR; Koehne G; Papadopoulos EB; Perales MA; van den Brink MR; Young JW; Boulad F; Kernan NA; Kobos R; Prockop S; Scaradavou A; Small T; O'Reilly RJ; Barker JN
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1316-26. PubMed ID: 21232625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.
    Kögler G; Somville T; Göbel U; Hakenberg P; Knipper A; Fischer J; Adams O; Krempe C; McKenzie C; Rüttgers H; Meier W; Bellmann O; Streng H; Ring A; Rosseck U; Rocha V; Wernet P
    Klin Padiatr; 1999; 211(4):224-32. PubMed ID: 10472555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.
    Dumont-Lagacé M; Feghaly A; Meunier MC; Finney M; Van't Hof W; Masson Frenet E; Sauvageau G; Cohen S
    Transplant Cell Ther; 2022 Jul; 28(7):410.e1-410.e5. PubMed ID: 35311667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.
    Barker JN; Krepski TP; DeFor TE; Davies SM; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2002; 8(5):257-60. PubMed ID: 12064362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.
    Fingrut WB; Davis E; Archer A; Brown S; Devlin S; Nhaissi M; Rapoport C; Chinapen S; Kelly A; Wells D; Scaradavou A; Gyurkocza B; Papadopoulos E; Politikos I; Shaffer BC; Barker JN
    Blood Adv; 2024 Jun; 8(11):2753-2764. PubMed ID: 38429097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.
    Soni S; Boulad F; Cowan MJ; Scaradavou A; Dahake J; Edwards S; Walters MC
    Pediatr Blood Cancer; 2014 Sep; 61(9):1690-4. PubMed ID: 24803091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Cord Blood Total Nucleated and CD34
    Barker JN; Mazis CM; Devlin SM; Davis E; Maloy MA; Naputo K; Nhaissi M; Wells D; Scaradavou A; Politikos I
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):734-744. PubMed ID: 31756534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.
    Fingrut WB; Gyurkocza B; Flynn J; Davis E; Devlin S; Scaradavou A; Chinapen S; Quach S; Cho C; Giralt SA; Jakubowski AA; Lin RJ; Papadopoulos EB; Perales MA; Ponce D; Shaffer BC; Tamari R; Young JW; Politikos I; Barker JN
    Blood Adv; 2023 Aug; 7(15):3824-3833. PubMed ID: 36240477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA typing and haematopoietic stem cell transplantation in the histocompatibility unit of the Ibn Sina University Hospital in Rabat (Morocco).
    Brick C; Atouf O; Ouadghiri S; Drissi Bourhanbour A; Bougar S; Yakhlef I; Essakalli M
    Transfus Clin Biol; 2019 Nov; 26(4):293-298. PubMed ID: 30366818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of partially mismatched related donors extends access to allogeneic marrow transplant.
    Henslee-Downey PJ; Abhyankar SH; Parrish RS; Pati AR; Godder KT; Neglia WJ; Goon-Johnson KS; Geier SS; Lee CG; Gee AP
    Blood; 1997 May; 89(10):3864-72. PubMed ID: 9160695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of unrelated umbilical cord blood hematopoietic stem cell transplant.
    Gluckman E; Rocha V; Chevret S
    Transfus Clin Biol; 2001 Jun; 8(3):146-54. PubMed ID: 11499955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.